Cargando…

Targeting Cancer Stem Cells by Oncolytic Viruses and Nano-Mediated Delivery

Detalles Bibliográficos
Autores principales:	Hosseini, Mahsa, Farassati, Fatemeh S, Farassati, Faris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519821/ https://www.ncbi.nlm.nih.gov/pubmed/33061422 http://dx.doi.org/10.2147/OTT.S279639

Ejemplares similares

Editorial announcing PubMed indexing of Oncolytic Virotherapy
por: Farassati, Faris
Publicado: (2017)

Cancer stem cells, the ultimate targets in cancer therapy
por: Shabbir, Ahmed, et al.
Publicado: (2018)

The role of KPNβ(1) in neuro-oncology
por: Lilley, Megan, et al.
Publicado: (2017)

Ezh2, a novel target in detection and therapy of breast cancer
por: Pourakbar, Sarah, et al.
Publicado: (2017)

Utilizing Ras Signaling Pathway to Direct Selective Replication of Herpes Simplex Virus-1
por: Pan, Weihong, et al.
Publicado: (2009)

Ras Signalling Pathway: A Gateway for HSV-1 Infection
por: Farassati, Faris, et al.
Publicado: (2003)

Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran
por: Boostani, Farnaz, et al.
Publicado: (2018)

Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
por: Yokoda, Raquel, et al.
Publicado: (2017)

A novel KRAS gene mutation report in sporadic colorectal cancer, from Northwest of Iran
por: Dolatkhah, Roya, et al.
Publicado: (2017)

Main Risk Factors Association with Proto-Oncogene Mutations in Colorectal Cancer
por: Dolatkhah, Roya, et al.
Publicado: (2018)

Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patients
por: Frahm, Silke, et al.
Publicado: (2004)

Colorectal Cancer in Iran: Molecular Epidemiology and Screening Strategies
por: Dolatkhah, Roya, et al.
Publicado: (2015)

Impact of RAS/RAF mutations on clinical and prognostic outcomes in metastatic colorectal cancer
por: Dolatkhah, Roya, et al.
Publicado: (2021)

Oncolytic Viruses
por: Chen, Nanhai G., et al.
Publicado: (2012)

Inhibition of Mesothelin as a Novel Strategy for Targeting Cancer Cells
por: Wang, Kun, et al.
Publicado: (2012)

Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis
por: Dolatkhah, Roya, et al.
Publicado: (2015)

Oncolytic Virus Immunotherapy
por: Marchini, Antonio, et al.
Publicado: (2021)

THU556 Targeting Breast Cancer Stem Cells With Oncolytic Virus
por: Roman Ortiz, Natasha Ivelisse, et al.
Publicado: (2023)

Oncolytic Virus-Mediated RAS Targeting in Rhabdomyosarcoma
por: Phelps, Michael P., et al.
Publicado: (2018)

Polymeric Cups for Cavitation-mediated Delivery of Oncolytic Vaccinia Virus
por: Myers, Rachel, et al.
Publicado: (2016)

Oncolytic viruses: Narcissistic or altruistic arsonists?
por: Kendall, Luke, et al.
Publicado: (2023)

Identifying the main barriers for participation in a population-based colorectal cancer screening programme in East Azerbaijan, Iran
por: Dolatkhah, Roya, et al.
Publicado: (2022)

Association between proto-oncogene mutations and clinicopathologic characteristics and overall survival in colorectal cancer in East Azerbaijan, Iran
por: Dolatkhah, Roya, et al.
Publicado: (2016)

Targeting Pediatric Cancer Stem Cells with Oncolytic Virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2012)

Oncolytic viral therapy: targeting cancer stem cells
por: Smith, Tyrel T, et al.
Publicado: (2014)

Cross-cultural validation of stool Based Colorectal cancer screening methods in the North West of Iran
por: Dolatkhah, Roya, et al.
Publicado: (2022)

Emerging Nano-/Biotechnology Drives Oncolytic Virus-Activated and Combined Cancer Immunotherapy
por: Fang, Chao, et al.
Publicado: (2023)

Editorial of the Special Issue: Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer
por: Guo, Zong Sheng, et al.
Publicado: (2017)

Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
por: Ferguson, Mark S., et al.
Publicado: (2012)

Oncolytic viruses & their specific targeting to tumour cells
por: Singh, Prafull K., et al.
Publicado: (2012)

Treatment of breast cancer stem cells with oncolytic herpes simplex virus
por: Li, J, et al.
Publicado: (2012)

Mesenchymal stem cells and oncolytic viruses: joining forces against cancer
por: Moreno, Rafael
Publicado: (2021)

Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer
por: Mooney, Rachael, et al.
Publicado: (2020)

Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer
por: Mooney, Rachael, et al.
Publicado: (2018)

Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
por: Kardani, Kimia, et al.
Publicado: (2023)

Medicine embraces nano: diagnostics to delivery
por: Singh, Surinder P, et al.
Publicado: (2018)

Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery
por: Ghaleh, Hadi Esmaeili Gouvarchin, et al.
Publicado: (2023)

Ultrasound-mediated oncolytic virus delivery and uptake for increased therapeutic efficacy: state of art
por: Nande, Rounak, et al.
Publicado: (2015)

NSCs are permissive to oncolytic Myxoma virus and provide a delivery method for targeted ovarian cancer therapy
por: Cornejo, Yvonne, et al.
Publicado: (2020)

Oncolytic Virus Immunotherapy: Showcasing Impressive Progress in Special Issue II
por: Guo, Zong-Sheng
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m77pnmo3grokrtp084fcoftrb5